Related Experiment Videos
Infection and inflammation and the coagulation system
Marcel Levi1, Tymen T Keller, Eric van Gorp
1Department of Vascular Medicine and Internal Medicine (F-4), Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. m.m.levi@amc.uva.nl
Cardiovascular Research
|October 3, 2003
Summary
Severe infections trigger hemostatic abnormalities and coagulation activation. Understanding the interplay between inflammation and coagulation offers promising therapeutic strategies for critical illnesses.
Area of Science:
- Hematology
- Immunology
- Pathophysiology
Background:
- Severe infections and systemic inflammation invariably cause hemostatic abnormalities.
- These abnormalities range from minor lab changes to severe disseminated intravascular coagulation (DIC).
- Pro-inflammatory cytokines critically influence coagulation and fibrinolysis pathways.
Purpose of the Study:
- To elucidate the intricate relationship between inflammation and coagulation.
- To highlight how systemic inflammation impacts hemostasis.
- To explore the therapeutic potential of modulating these pathways.
Main Methods:
- Review of existing literature on infection, inflammation, and coagulation.
- Analysis of cytokine-mediated effects on hemostatic pathways.
- Examination of specific infectious diseases with distinct hemostatic features.
Main Results:
- Systemic inflammation activates coagulation via tissue factor, downregulates anticoagulants, and inhibits fibrinolysis.
- Coagulation system activation can reciprocally influence inflammatory responses.
- Specific infections present unique hemostatic challenges like hemorrhagic fever or thrombotic microangiopathy.
Conclusions:
- The crosstalk between inflammation and coagulation is a critical factor in severe infections.
- Targeting modulators of coagulation and inflammation shows promise for treating severe systemic infections.
- Further research into this bidirectional relationship is warranted for improved patient outcomes.